Jerusalem Measles Outbreak Carried a Heavy Toll in Young Unvaccinated Children
Jerusalem’s 2025–2026 measles outbreak produced 1,289 reported cases and 11 childhood deaths, a mortality burden that far exceeded what is usually expected in a city with advanced medical care and ready access to vaccination. The outbreak rate reached 129.2 cases per 100,000 population in Jerusalem, and nearly 71% of cases were in children younger than 5 years. The deaths clustered in very young children: the median age among those who died was 1.4 years. Most fatal cases occurred in children who had never been vaccinated, and the sharpest mortality burden fell in six ultraorthodox neighborhoods where vaccine coverage had collapsed to about 55% before the outbreak began.
The numbers point to a classic measles failure pattern: a highly contagious virus, densely populated households, and too few immune children to interrupt transmission.
Mortality Concentrated Where Coverage Was Lowest
Among the 1,289 Jerusalem case-patients, 870 were unvaccinated and 42 had received a single dose. Most patients who fell ill lived in the six neighborhoods, even though those areas held only 6.8% of Jerusalem’s population younger than 5 years. Children in those neighborhoods accounted for 71.9% of measles cases in that age group, and the measles-specific mortality rate among children younger than 5 years reached 80.1 deaths per 100,000 population there. Across Jerusalem as a whole, the measles-specific mortality rate among children younger than 5 years was 7.7 deaths per 100,000 population.
Eleven of the 1,289 Jerusalem case-patients died, yielding a case-fatality rate of 0.85%. Across Israel, 17 deaths were reported, and Jerusalem accounted for 64.7% of them. The death burden was especially striking because 10 of the 11 children who died were otherwise healthy. Nine of those 10 were younger than 3 years, had never been vaccinated, and were not registered in mother-and-child health clinics. One 7-year-old child had truncus arteriosus and had received a single MMRV dose at 1 year of age, but not the second dose.
Delayed Care Marked the Fatal Cases
Clinical deterioration was advanced by the time many children reached medical care. The median interval from first symptom — fever or rash — to emergency department visit was 8 days, and death was reported a median of 15 days after symptom onset. Six children were dead on arrival. Five were hospitalized for a median of 21 days, and three required extracorporeal membrane oxygenation.
Those intervals matter because measles can progress from fever and rash to severe pneumonia, respiratory failure, and invasive bacterial disease in a matter of days, especially in toddlers. Eight of the children who died had radiographic evidence of pneumonia at admission, and six had positive blood cultures. The pattern is consistent with a virus that damages the respiratory epithelium, disrupts immune defenses, and opens the door to secondary infection. Measles does not simply cause a rash; it can trigger a systemic collapse in host defense during the same window in which families may still be trying home-based or community-based management.
Household Crowding and Community Transmission Fueled Exposure
The median household size among case-patients who died was 7 people, with some homes reporting 1 to 3 additional family members with measles. Crowding increases the in-home viral inoculum and repeats exposure at the exact stage of life when infants and toddlers are least protected. In Jerusalem’s six neighborhoods, the first-dose measles coverage stood at about 55% at the start of the outbreak. With MMR vaccine efficacy of 95% at 12 months, an estimated 47.7% of infants in each birth cohort remained unprotected.
That combination created a fragile setting for explosive transmission. Measles spreads efficiently in households, schools, and tightly connected community networks, and the outbreak data show how quickly that transmission can translate into severe pediatric disease when immunity is patchy.
Genotype B3 Matched Strains Seen in Other Outbreaks
Sequencing of available samples from two deceased children identified measles genotype B3. The sequences matched the B3-named strain MVs/Quetta.PAK/44.20, a strain linked to previous measles outbreaks in Europe. Genotyping does not explain the mortality by itself, but it confirms that the outbreak involved a recognized circulating lineage rather than an isolated laboratory artifact or one-off event.
Laboratory confirmation was obtained by reverse transcription PCR in 9 of the 11 fatal cases. Two additional children were classified through clinical presentation and epidemiologic linkage. Those methods fit the reality of outbreak investigation, where some patients deteriorate or die before comprehensive sampling can be completed.
Trust Gaps Shaped When Families Sought Care
The timing of presentation suggests more than virology alone. Community behavior appears to have played a major role in delaying treatment. Some parents first consulted community mediators, including people with backgrounds as medical orderlies or midwives, when the child became visibly worse. Those mediators reportedly used pulse oximeters, sometimes recommended vitamin A, and in some cases gave intravenous fluids before hospital referral. Six of the 11 children who died arrived at the hospital already dead.
Public health response in this setting has to account for more than access. Vaccine hesitancy, mistrust of government institutions, and reluctance to seek outside care can all deepen the hazard of an outbreak that otherwise might have been contained earlier. The report also links this behavior to experiences during COVID-19, when coercive measures and isolation intensified skepticism in some ultraorthodox communities. A high spiritual locus of control may further reduce willingness to vaccinate when illness is viewed through the lens of divine rather than biomedical control.
The Outbreak Exposed a Preventable Mortality Gap
Jerusalem’s measles death burden is difficult to separate from undercounting of cases. A back-calculation based on the 11 observed deaths suggests the actual number of infections may have been substantially higher than surveillance captured, which is why the measles-specific mortality rate provides a more stable population-based measure than case-fatality alone. Even so, the central clinical message is hard to miss: a city with substantial medical infrastructure still saw severe child mortality when vaccination coverage fell and families delayed care.
The outbreak also revived concern about immune suppression and immune amnesia after measles infection. Secondary infections may have worsened outcomes, and longer follow-up could reveal additional illness or death among recovering children. For clinicians and public health teams, the practical target is no mystery. Early vaccination, earlier referral, and community-specific trust building are the only measures capable of interrupting the pattern that drove these deaths.